FDA Advisers Vote Against Experimental ALS Treatment Pushed By Patients Background In a recent meeting, federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis (ALS). This decision comes after years of effort by patients seeking access to the unproven therapy. The treatment in question, called […]